Carlsmed (CARL) Receivables (2024 - 2026)

Carlsmed's Receivables history runs 3 years deep, the most recent figure standing at $12.3 million for Q1 2026.

• Quarterly Receivables changed N/A year-over-year to $12.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $12.3 million (changed N/A YoY) and the FY2025 annual result came in at $11.4 million, up 67.93% from the prior year.
• Receivables was $12.3 million for Q1 2026 at Carlsmed, up from $11.4 million in the prior quarter.
• Across five years, Receivables topped out at $12.3 million in Q1 2026 and bottomed at $6.8 million in Q4 2024.
• A 3-year average of $10.3 million and a median of $11.3 million in 2025 frame the typical range for Receivables.
• Peak annual rise in Receivables reached 67.93% in 2025, while the deepest fall reached 67.93% in 2025.
• Carlsmed's Receivables stood at $6.8 million in 2024, then surged by 67.93% to $11.4 million in 2025, then gained by 7.97% to $12.3 million in 2026.
• Business Quant data shows CARL's Receivables at $12.3 million in Q1 2026, $11.4 million in Q4 2025, and $11.3 million in Q3 2025.